Search Results - "Lowell, Jeffrey A"

Refine Results
  1. 1

    Involvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression by Medina-Rodriguez, Eva M, Lowell, Jeffrey A, Worthen, Ryan J, Syed, Shariful A, Beurel, Eléonore

    Published in Frontiers in neuroscience (17-08-2018)
    “…Major depressive disorder (MDD) is a prevalent and debilitating disorder, often fatal. Treatment options are few and often do not provide immediate relief to…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation by Chapman, William C, Majella Doyle, M B, Stuart, Jourdan E, Vachharajani, Neeta, Crippin, Jeffrey S, Anderson, Christopher D, Lowell, Jeffrey A, Shenoy, Surendra, Darcy, Michael D, Brown, Daniel B

    Published in Annals of surgery (01-10-2008)
    “…To evaluate outcomes of downstaging patients with advanced (American liver tumor study group stage III/IV) hepatocellular carcinoma (HCC) with transarterial…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Th17 cells in depression by Beurel, Eléonore, Lowell, Jeffrey A.

    Published in Brain, behavior, and immunity (01-03-2018)
    “…•Th17 cells are increased in the blood of depressed patients.•Th17 cells promote depressive-like behaviors in mice.•Th17 cells are pathogenic in most CNS…”
    Get full text
    Journal Article
  6. 6
  7. 7

    AAV8 transduction capacity is reduced by prior exposure to endosome-like pH conditions by Lowell, Jeffrey, Mah, Kar, Bixby, John, Lemmon, Vance

    Published in Neural regeneration research (01-05-2021)
    “…Adeno-associated virus (AAV) is an essential instrument in the neuroscientist's toolkit, which allows delivery of DNA to provide labeling with fluorescent…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Pre-Liver Transplantation Locoregional Adjuvant Therapy for Hepatocellular Carcinoma as a Strategy to Improve Longterm Survival by Bharat, Ankit, Brown, Daniel B., Crippin, Jeffrey S., Gould, Jennifer E., Lowell, Jeffrey A., Shenoy, Surendra, Desai, Niraj M., Chapman, William C.

    “…Preorthotopic liver transplantation locoregional therapy (LRT) for hepatocellular carcinoma (HCC) reduces drop-out rates in patients awaiting orthotopic liver…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease by Lowell, Jeffrey A, Farber, Michael J, Sultan, Keith

    Published in World journal of gastroenterology : WJG (07-07-2024)
    “…Inflammatory bowel disease (IBD) is entering a potentially new era of combined therapeutics. Triantafillidis provide an insightful review of the current state…”
    Get full text
    Journal Article
  13. 13

    Pharmacologic Anticoagulation Is Associated With a Lower Risk of Recurrent Venous Thromboembolic Events During Janus Kinase Inhibitor Use for Patients With a Prior Thrombosis by Lowell, Jeffrey A, Sharma, Garvita, Swaminath, Arun, Sultan, Keith

    Published in Inflammatory bowel diseases (04-05-2024)
    “…Janus kinase (JAK) inhibitors tofacitinib and upadacitinib are effective therapies for inflammatory bowel disease and rheumatologic disorders but currently…”
    Get full text
    Journal Article
  14. 14

    Recurrent primary biliary cirrhosis: Peritransplant factors and ursodeoxycholic acid treatment post‐liver transplant by Guy, Jennifer E., Qian, Peiqing, Lowell, Jeffrey A., Peters, Marion G.

    Published in Liver transplantation (01-10-2005)
    “…Primary biliary cirrhosis (PBC) recurs after orthotopic liver transplantation (OLT) in up to one‐third of patients. These patients are typically asymptomatic,…”
    Get full text
    Journal Article
  15. 15

    Distinct characteristics of hippocampal pathogenic TH17 cells in a mouse model of depression by Beurel, Eléonore, Lowell, Jeffrey A., Jope, Richard S.

    Published in Brain, behavior, and immunity (01-10-2018)
    “…•TH17 cells promote depressive-like behavior.•TH17 cells increase in the hippocampus in learned helpless mice.•Hippocampal TH17 cells exhibit pathogenic (CCR6,…”
    Get full text
    Journal Article
  16. 16

    Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis by Lowell, Jeffrey A., Sharma, Garvita, Chua, Vincent, Ben-Horin, Shomron, Swaminath, Arun, Sultan, Keith

    Published in Digestive diseases and sciences (01-10-2024)
    “…Background and Aims Patients with inflammatory bowel disease (IBD) receiving infliximab (IFX) commonly experience immunogenic loss of response (LOR) by…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Stressed and Inflamed, Can GSK3 Be Blamed? by Jope, Richard S., Cheng, Yuyan, Lowell, Jeffrey A., Worthen, Ryan J., Sitbon, Yoel H., Beurel, Eleonore

    “…Psychological stress has a pervasive influence on our lives. In many cases adapting to stress strengthens organisms, but chronic or severe stress is usually…”
    Get full text
    Journal Article
  19. 19
  20. 20